312 related articles for article (PubMed ID: 29927903)
1. Expression of the Marburg I Single Nucleotide Polymorphism (MI-SNP) and the Marburg II Single Nucleotide Polymorphism (MII-SNP) of the Factor VII-Activating Protease (FSAP) Gene and Risk of Coronary Artery Disease (CAD): A Pilot Study in a Single Population.
Parahuleva MS; Schieffer B; Klassen M; Worsch M; Parviz B; Hölschermann H
Med Sci Monit; 2018 Jun; 24():4271-4278. PubMed ID: 29927903
[TBL] [Abstract][Full Text] [Related]
2. The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
Etscheid M; Muhl L; Pons D; Jukema JW; König H; Kanse SM
Thromb Res; 2012 Dec; 130(6):935-41. PubMed ID: 22906531
[TBL] [Abstract][Full Text] [Related]
3. The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events.
Ahmad-Nejad P; Dempfle CE; Weiss C; Bugert P; Borggrefe M; Neumaier M
Thromb Res; 2012 Sep; 130(3):441-4. PubMed ID: 22421107
[TBL] [Abstract][Full Text] [Related]
4. The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation.
Sedding D; Daniel JM; Muhl L; Hersemeyer K; Brunsch H; Kemkes-Matthes B; Braun-Dullaeus RC; Tillmanns H; Weimer T; Preissner KT; Kanse SM
J Exp Med; 2006 Dec; 203(13):2801-7. PubMed ID: 17145954
[TBL] [Abstract][Full Text] [Related]
5. Factor VII activating protease. Single nucleotide polymorphisms light the way.
Kanse SM; Etscheid M
Hamostaseologie; 2011 Aug; 31(3):174-6, 177-8. PubMed ID: 21655671
[TBL] [Abstract][Full Text] [Related]
6. Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men.
Borkham-Kamphorst E; Zimmermann HW; Gassler N; Bissels U; Bosio A; Tacke F; Weiskirchen R; Kanse SM
J Hepatol; 2013 Jan; 58(1):104-11. PubMed ID: 22989567
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: a meta-analysis.
Han H; Wang H; Yin Z; Jiang H; Fang M; Han J
Gene; 2013 Sep; 526(2):134-41. PubMed ID: 23685282
[TBL] [Abstract][Full Text] [Related]
8. Factor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation.
Daniel JM; Reichel CA; Schmidt-Woell T; Dutzmann J; Zuchtriegel G; Krombach F; Herold J; Bauersachs J; Sedding DG; Kanse SM
J Thromb Haemost; 2016 Oct; 14(10):2058-2067. PubMed ID: 27431088
[TBL] [Abstract][Full Text] [Related]
9. DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke.
Li WJ; Yin RX; Cao XL; Chen WX; Huang F; Wu JZ
Lipids Health Dis; 2018 Feb; 17(1):30. PubMed ID: 29454388
[TBL] [Abstract][Full Text] [Related]
10. Factor VII activating protease (FSAP) regulates the expression of inflammatory genes in vascular smooth muscle and endothelial cells.
Byskov K; Boettger T; Ruehle PF; Nielsen NV; Etscheid M; Kanse SM
Atherosclerosis; 2017 Oct; 265():133-139. PubMed ID: 28881271
[TBL] [Abstract][Full Text] [Related]
11. The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk.
Tragante V; Doevendans PA; Nathoe HM; van der Graaf Y; Spiering W; Algra A; de Borst GJ; de Bakker PI; Asselbergs FW;
Eur Heart J; 2013 Oct; 34(37):2896-904. PubMed ID: 23828831
[TBL] [Abstract][Full Text] [Related]
12. The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease.
Osadnik T; Strzelczyk JK; Lekston A; Reguła R; Bujak K; Fronczek M; Gawlita M; Gonera M; Wasilewski J; Szyguła-Jurkiewicz B; Gierlotka M; Gąsior M
BMC Cardiovasc Disord; 2016 Nov; 16(1):218. PubMed ID: 27835972
[TBL] [Abstract][Full Text] [Related]
13. Monocyte chemoattractant protein-1 gene (MCP-1) polymorphisms are associated with risk of premature coronary artery disease in Mexican patients from the Genetics of Atherosclerotic Disease (GEA) study.
Angeles-Martínez J; Posadas-Sánchez R; Álvarez-León E; Villarreal-Molina T; Cardoso-Saldaña G; Fragoso JM; Juárez-Rojas JG; Medina-Urrutia A; Posadas-Romero C; Vargas-Alarcón G
Immunol Lett; 2015 Oct; 167(2):125-30. PubMed ID: 26277553
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in dipeptidyl peptidase IV gene are associated with the risk of myocardial infarction in patients with atherosclerosis.
Aghili N; Devaney JM; Alderman LO; Zukowska Z; Epstein SE; Burnett MS
Neuropeptides; 2012 Dec; 46(6):367-71. PubMed ID: 23122333
[TBL] [Abstract][Full Text] [Related]
15. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism.
Gulesserian T; Hron G; Endler G; Eichinger S; Wagner O; Kyrle PA
Thromb Haemost; 2006 Jan; 95(1):65-7. PubMed ID: 16543963
[TBL] [Abstract][Full Text] [Related]
16. Circulating factor VII activating protease (FSAP) is associated with clinical outcome in acute coronary syndrome.
Parahuleva MS; Hölschermann H; Zandt D; Pons-Kühnemann J; Parviz B; Weiskirchen R; Staubitz A; Tillmanns H; Erdogan A; Kanse SM
Circ J; 2012; 76(11):2653-61. PubMed ID: 22850287
[TBL] [Abstract][Full Text] [Related]
17. Qualitative detection of the Marburg I alloenzyme of factor VII-activating protease by an immunoassay and its comparison to PCR testing.
Schwarz H; Stephan S; Sidelmann JJ; Fischer B; Althaus H; Hahn M; Kappel A; Ehm M; Vitzthum F
Clin Chem Lab Med; 2010 Dec; 48(12):1745-9. PubMed ID: 20828365
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism in the chemokine receptor 7 gene (CCR7) is associated with previous myocardial infarction in patients undergoing elective coronary angiography.
Wołkow PP; Drabik L; Totoń-Żurańska J; Kuś K; Foryś J; Słowik A; Pera J; Godlewski J; Tomala M; Żmudka K; Olszanecki R; Jawień J; Korbut R
Int J Immunogenet; 2016 Aug; 43(4):218-25. PubMed ID: 27317472
[TBL] [Abstract][Full Text] [Related]
19. The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP).
Roemisch J; Feussner A; Nerlich C; Stoehr HA; Weimer T
Blood Coagul Fibrinolysis; 2002 Jul; 13(5):433-41. PubMed ID: 12138371
[TBL] [Abstract][Full Text] [Related]
20. Marburg I polymorphism of factor VII--activating protease: a prominent risk predictor of carotid stenosis.
Willeit J; Kiechl S; Weimer T; Mair A; Santer P; Wiedermann CJ; Roemisch J
Circulation; 2003 Feb; 107(5):667-70. PubMed ID: 12578864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
